Related Experiment Videos
Molecular pathology of tumor metastasis III. Target array and combinatorial therapies
József Tímár1, Andrea Ladányi, István Peták
1National Institute of Oncology, Budapest, Hungary. jtimar@oncol.hu
Abstract:
Therapy of tumor progression and the metastatic disease is the biggest challenge of clinical oncology. Discovery of the diverse molecular pathways behind this complex disease outlined an approach to better treatment strategies. The development of combined cytotoxic treatment protocols has produced promising results but no breakthrough in the clinical management of metastatic disease. The multiple - specific and non-specific pathways and cellular targets of tumor progression are outlined in this review. Such an approach, individually designed for various cancer types, may have a better chance to treat or even cure cancer patients with progressive disease.
Insights
Treating advanced cancer and metastasis remains a major challenge in oncology. This review outlines molecular pathways and targets for developing personalized combination therapies to improve patient outcomes.
Area of Science:
- Oncology
- Cancer Biology
- Molecular Pathways
Background:
- Metastatic disease and tumor progression represent significant challenges in clinical oncology.
- Understanding the molecular underpinnings of cancer is crucial for developing effective treatments.
Purpose of the Study:
- To review the diverse molecular pathways involved in tumor progression and metastasis.
- To explore the potential of combination therapies targeting multiple pathways for improved cancer treatment.
Main Methods:
- Literature review of molecular pathways in cancer progression.
- Analysis of current treatment strategies and their limitations.
- Identification of specific and non-specific cellular targets.
Main Results:
- Combined cytotoxic treatments show promise but have not led to a breakthrough.
- Multiple specific and non-specific pathways drive tumor progression.
- Personalized, multi-targeted approaches are needed for different cancer types.
Conclusions:
- Tailoring treatment strategies to individual cancer types by targeting multiple pathways offers a promising approach.
- Personalized combination therapies may improve the chances of treating or curing patients with progressive metastatic disease.